Current advances of plant-based vaccines for neurodegenerative diseases

Neurodegenerative diseases (NDDs) are characterized by the progressive degeneration and/or loss of neurons belonging to the central nervous system, and represent one of the major global health issues. Therefore, a number of immunotherapeutic approaches targeting the non-functional or toxic proteins...

Descripción completa

Detalles Bibliográficos
Autores principales: Bravo-Vázquez, Luis Alberto, Mora-Hernández, Erick Octavio, Rodríguez, Alma L., Sahare, Padmavati, Bandyopadhyay, Anindya, Duttaroy, Asim K., Paul, Sujay
Formato: Journal Article
Lenguaje:Inglés
Publicado: MDPI 2023
Materias:
Acceso en línea:https://hdl.handle.net/10568/163981
_version_ 1855537578051108864
author Bravo-Vázquez, Luis Alberto
Mora-Hernández, Erick Octavio
Rodríguez, Alma L.
Sahare, Padmavati
Bandyopadhyay, Anindya
Duttaroy, Asim K.
Paul, Sujay
author_browse Bandyopadhyay, Anindya
Bravo-Vázquez, Luis Alberto
Duttaroy, Asim K.
Mora-Hernández, Erick Octavio
Paul, Sujay
Rodríguez, Alma L.
Sahare, Padmavati
author_facet Bravo-Vázquez, Luis Alberto
Mora-Hernández, Erick Octavio
Rodríguez, Alma L.
Sahare, Padmavati
Bandyopadhyay, Anindya
Duttaroy, Asim K.
Paul, Sujay
author_sort Bravo-Vázquez, Luis Alberto
collection Repository of Agricultural Research Outputs (CGSpace)
description Neurodegenerative diseases (NDDs) are characterized by the progressive degeneration and/or loss of neurons belonging to the central nervous system, and represent one of the major global health issues. Therefore, a number of immunotherapeutic approaches targeting the non-functional or toxic proteins that induce neurodegeneration in NDDs have been designed in the last decades. In this context, due to unprecedented advances in genetic engineering techniques and molecular farming technology, pioneering plant-based immunogenic antigen expression systems have been developed aiming to offer reliable alternatives to deal with important NDDs, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Diverse reports have evidenced that plant-made vaccines trigger significant immune responses in model animals, supported by the production of antibodies against the aberrant proteins expressed in the aforementioned NDDs. Moreover, these immunogenic tools have various advantages that make them a viable alternative for preventing and treating NDDs, such as high scalability, no risk of contamination with human pathogens, cold chain free production, and lower production costs. Hence, this article presents an overview of the current progress on plant-manufactured vaccines for NDDs and discusses its future prospects.
format Journal Article
id CGSpace163981
institution CGIAR Consortium
language Inglés
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher MDPI
publisherStr MDPI
record_format dspace
spelling CGSpace1639812025-12-08T10:29:22Z Current advances of plant-based vaccines for neurodegenerative diseases Bravo-Vázquez, Luis Alberto Mora-Hernández, Erick Octavio Rodríguez, Alma L. Sahare, Padmavati Bandyopadhyay, Anindya Duttaroy, Asim K. Paul, Sujay pharmaceutical science Neurodegenerative diseases (NDDs) are characterized by the progressive degeneration and/or loss of neurons belonging to the central nervous system, and represent one of the major global health issues. Therefore, a number of immunotherapeutic approaches targeting the non-functional or toxic proteins that induce neurodegeneration in NDDs have been designed in the last decades. In this context, due to unprecedented advances in genetic engineering techniques and molecular farming technology, pioneering plant-based immunogenic antigen expression systems have been developed aiming to offer reliable alternatives to deal with important NDDs, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Diverse reports have evidenced that plant-made vaccines trigger significant immune responses in model animals, supported by the production of antibodies against the aberrant proteins expressed in the aforementioned NDDs. Moreover, these immunogenic tools have various advantages that make them a viable alternative for preventing and treating NDDs, such as high scalability, no risk of contamination with human pathogens, cold chain free production, and lower production costs. Hence, this article presents an overview of the current progress on plant-manufactured vaccines for NDDs and discusses its future prospects. 2023-02-20 2024-12-19T12:53:18Z 2024-12-19T12:53:18Z Journal Article https://hdl.handle.net/10568/163981 en Open Access MDPI Bravo-Vázquez, Luis Alberto; Mora-Hernández, Erick Octavio; Rodríguez, Alma L.; Sahare, Padmavati; Bandyopadhyay, Anindya; Duttaroy, Asim K. and Paul, Sujay. 2023. Current advances of plant-based vaccines for neurodegenerative diseases. Pharmaceutics, Volume 15 no. 2 p. 711
spellingShingle pharmaceutical science
Bravo-Vázquez, Luis Alberto
Mora-Hernández, Erick Octavio
Rodríguez, Alma L.
Sahare, Padmavati
Bandyopadhyay, Anindya
Duttaroy, Asim K.
Paul, Sujay
Current advances of plant-based vaccines for neurodegenerative diseases
title Current advances of plant-based vaccines for neurodegenerative diseases
title_full Current advances of plant-based vaccines for neurodegenerative diseases
title_fullStr Current advances of plant-based vaccines for neurodegenerative diseases
title_full_unstemmed Current advances of plant-based vaccines for neurodegenerative diseases
title_short Current advances of plant-based vaccines for neurodegenerative diseases
title_sort current advances of plant based vaccines for neurodegenerative diseases
topic pharmaceutical science
url https://hdl.handle.net/10568/163981
work_keys_str_mv AT bravovazquezluisalberto currentadvancesofplantbasedvaccinesforneurodegenerativediseases
AT morahernandezerickoctavio currentadvancesofplantbasedvaccinesforneurodegenerativediseases
AT rodriguezalmal currentadvancesofplantbasedvaccinesforneurodegenerativediseases
AT saharepadmavati currentadvancesofplantbasedvaccinesforneurodegenerativediseases
AT bandyopadhyayanindya currentadvancesofplantbasedvaccinesforneurodegenerativediseases
AT duttaroyasimk currentadvancesofplantbasedvaccinesforneurodegenerativediseases
AT paulsujay currentadvancesofplantbasedvaccinesforneurodegenerativediseases